Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Apexbio Technology LLC LJI308 1627709-94-7 25mg
Supplier: Apexbio Technology LLC B604325
LJI308 (CAS 1627709-94-7) is a potent and selective small-molecule inhibitor of p90 ribosomal S6 kinases (RSK1 RSK2 RSK3) with reported IC50 values ranging from 0 004 to 0 013 mM By targeting RSK kinases downstream effectors in the ERK/MAPK pathway LJI308 modulates signaling processes involved in cell survival proliferation and polarity In cellular assays LJI308 demonstrates concentration-dependent inhibition of colony formation and cell growth in cancer cell lines such as MDA-MB-231 and H358 while exerting minimal effects on non-tumorigenic cells LJI308 is utilized in studies exploring RSK signaling chemoresistance and the elimination of cancer stem cells particularly in triple-negative breast cancer models
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?